Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Depreciation and Depletion (2016 - 2017)

Intellia Therapeutics has reported Depreciation and Depletion over the past 3 years, most recently at $660000.0 for Q1 2017.

  • Quarterly Depreciation and Depletion rose 252.94% to $660000.0 in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Mar 2017, up 246.48% year-over-year, with the annual reading at $3.0 million for FY2017, 172.73% up from the prior year.
  • Depreciation and Depletion was $660000.0 for Q1 2017 at Intellia Therapeutics, up from $401000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $660000.0 in Q1 2017 and troughed at $33000.0 in Q1 2015.
  • The 3-year median for Depreciation and Depletion is $187000.0 (2016), against an average of $228888.9.
  • The largest YoY upside for Depreciation and Depletion was 466.67% in 2016 against a maximum downside of 176.04% in 2016.
  • A 3-year view of Depreciation and Depletion shows it stood at $104000.0 in 2015, then skyrocketed by 285.58% to $401000.0 in 2016, then surged by 64.59% to $660000.0 in 2017.
  • Per Business Quant, the three most recent readings for NTLA's Depreciation and Depletion are $660000.0 (Q1 2017), $401000.0 (Q4 2016), and $265000.0 (Q3 2016).